The ABCs of multidrug resistance in malaria

Trends in Parasitology

Volumn 26, Issue 9, 2010, Pages 440-446

  Koenderink, Jan B ^a   Kavishe, Reginald A ^b   Rijpma, Sanna R ^a   Russel, Frans G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMODIAQUINE; ARTEMISIN; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; MALARIA VACCINE; MULTIDRUG RESISTANCE PROTEIN 1; PIPERAQUINE; PRIMAQUINE; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIMALARIAL DRUG SUSCEPTIBILITY; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PLASMODIUM YOELII; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA; MODELS, MOLECULAR; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PARASITIC SENSITIVITY TESTS; PLASMODIUM; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 77955921335     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2010.05.002     Document Type: Review

References (64)

1. World Health Organization (2009) Malaria. Fact sheet No 94, World Health Organization (). http://www.who.int/mediacentre/factsheets/fs094/en/.
2. Langhorne J., et al. Immunity to malaria: more questions than answers. Nat. Immunol. 2008, 9:725-732.
3. Abdulla S., et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N. Engl. J. Med. 2008, 359:2533-2544.
4. Jambou R., et al. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 2005, 366:1960-1963.
5. Dondorp A.M., et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
6. Martin R.E., et al. Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 2009, 325:1680-1682.
7. Mu J., et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 2003, 49:977-989.
8. Reed M.B., et al. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000, 403:906-909.
9. Sidhu A.B., et al. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 2005, 57:913-926.
10. Borges-Walmsley M.I., et al. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 2003, 376:313-338.
11. Gardner M.J., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
12. Martin, R.E. et al. (2005) The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol. 6, R26 DOI:10.1186/gb-2005-6-3-r26 (). http://www.genomebiology.com/.
13. Kavishe R.A., et al. Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane. Malar. J. 2009, 8:205.
14. Sauvage V., et al. The role of ATP-binding cassette (ABC) proteins in protozoan parasites. Mol. Biochem. Parasitol. 2009, 167:81-94.
15. Gangwar D., et al. A systematic classification of Plasmodium falciparum P-loop NTPases: structural and functional correlation. Malar. J. 2009, 8:69.
16. Jones P.M., et al. ABC transporters: a riddle wrapped in a mystery inside an enigma. Trends Biochem. Sci. 2009, 34:520-531.
17. Cowman A.F., et al. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 1991, 113:1033-1042.
18. Rohrbach P., et al. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J. 2006, 25:3000-3011.
19. Foote S.J., et al. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 1989, 57:921-930.
20. Sidhu A.B., et al. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 2006, 194:528-535.
21. Wellems T.E., et al. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 1990, 345:253-255.
22. Barnes D.A., et al. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 1992, 11:3067-3075.
23. Elandaloussi L.M., et al. Analysis of P-glycoprotein expression in purified parasite plasma membrane and food vacuole from Plasmodium falciparum. Parasitol. Res. 2006, 99:631-637.
24. Picot S., et al. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar. J. 2009, 8:89.
25. Lim P., et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 2009, 8:11.
26. Preechapornkul P., et al. Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness. Antimicrob. Agents Chemother. 2009, 53:1509-1515.
27. Foote S.J., et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990, 345:255-258.
28. Price R.N., et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 2006, 42:1570-1577.
29. Humphreys G.S., et al. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 2007, 51:991-997.
30. Sa J.M., et al. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl. Acad. Sci. USA 2009, 106:18883-18889.
31. Hayward R., et al. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 2005, 55:1285-1295.
32. Mehlin C., et al. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol. Biochem. Parasitol. 2006, 148:144-160.
33. van Es H.H., et al. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine. Mol. Cell Biol. 1994, 14:2419-2428.
34. van Es H.H., et al. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene. Mol. Biochem. Parasitol. 1994, 68:209-219.
35. Volkman S.K., et al. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 1995, 92:8921-8925.
36. Amoah L.E., et al. Heterologous expression and ATPase activity of mutant versus wild type PfMDR1 protein. Biochemistry 2007, 46:6060-6073.
37. Lekostaj J.K., et al. A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform. Mol. Biochem. Parasitol. 2008, 157:107-111.
38. Sanchez C.P., et al. Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol. Microbiol. 2008, 70:786-798.
39. Sanchez C.P., et al. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Trends Parasitol. 2007, 23:332-339.
40. Rubio J.P., Cowman A.F. Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite. Exp. Parasitol. 1994, 79:137-147.
41. Zalis M.G., et al. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 1993, 62:83-92.
42. Ekong R.M., et al. Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Parasitology 1993, 106(Pt. 2):107-115.
43. Rosenberg E., et al. pfmdr2 confers heavy metal resistance to Plasmodium falciparum. J. Biol. Chem. 2006, 281:27039-27045.
44. Anderson T.J., et al. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?. Antimicrob. Agents Chemother. 2005, 49:2180-2188.
45. Klokouzas A., et al. ABC transporters and drug resistance in parasitic protozoa. Int. J. Antimicrob. Agents 2003, 22:301-317.
46. Nogueira F., et al. Plasmodium falciparum multidrug resistance protein (MRP) gene expression under chloroquine and mefloquine challenge. J. Cell Animal Biol. 2008, 2:10-20.
47. Dahlstrom S., et al. Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment. Antimicrob. Agents Chemother. 2009, 53:2553-2556.
48. Dahlstrom S., et al. Plasmodium falciparum Multidrug Resistance Protein 1 and Artemisinin-Based Combination Therapy in Africa. J. Infect. Dis. 2009, 200:1456-1464.
49. Raj D.K., et al. Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione. J. Biol. Chem. 2009, 284:7687-7696.
50. Vlaming M.L., et al. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv. Drug Deliv. Rev. 2009, 61:14-25.
51. Sammut S.J., et al. Pfam 10 years on: 10,000 families and still growing. Brief. Bioinform. 2008, 9:210-219.
52. Wells T.N., et al. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 2010, 26:145-151.
53. Mueller I., et al. Plasmodium malariae and Plasmodium ovale--the " bashful" malaria parasites. Trends Parasitol. 2007, 23:278-283.
54. Sa J.M., et al. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp. Parasitol. 2005, 109:256-259.
55. Brega S., et al. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J. Infect. Dis. 2005, 191:272-277.
56. Suwanarusk, R. et al. (2007) Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS. One. 2, e1089 DOI:10.1371/journal.pone.0001089 (). http://www.plosone.org/.
57. Suwanarusk R., et al. Amplification of pvmdr1 associated with multidrug- resistant Plasmodium vivax. J. Infect. Dis. 2008, 198:1558-1564.
58. Barnadas C., et al. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob. Agents Chemother. 2008, 52:4233-4240.
59. Imwong M., et al. Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob. Agents Chemother. 2008, 52:2657-2659.
60. Orjuela-Sanchez P., et al. Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region. Antimicrob. Agents Chemother. 2009, 53:3561-3564.
61. Fernandez-Becerra C., et al. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Malar. J. 2009, 8:55.
62. Aller S.G., et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009, 323:1718-1722.
63. Larkin M.A., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
64. Page R.D. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 1996, 12:357-358.